MyJournals Home  

RSS FeedsDownregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients (BMC Medical Genomics)

 
 

6 august 2022 17:22:35

 
Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients (BMC Medical Genomics)
 


TIR domain containing adaptor molecule 1 (TICAM1) is a coding gene participating in immune and inflammation responses to malignant cells. However, the role of TICAM1 in Wilms tumor (WT) is rarely known.


 
63 viewsCategory: Genomics, Medicine
 
Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis (BMC Medical Genomics)
Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients (BMC Medical Genomics)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2022 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten